Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

OBJECTIVE: Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation. Although fingolimod-associated lymphopenia is a well-known phenomenon, the exact cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Maxi, Haase, Rocco, Proschmann, Undine, Ziemssen, Tjalf, Akgün, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256977/
https://www.ncbi.nlm.nih.gov/pubmed/30524432
http://dx.doi.org/10.3389/fimmu.2018.02669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256977/
https://www.ncbi.nlm.nih.gov/pubmed/30524432
http://dx.doi.org/10.3389/fimmu.2018.02669

Ejemplares similares